We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

Microscopic image of a group of bacteria cells

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

A 3D model of a human heart.

Machine Learning Reveals Sex Disparities in Heart Disease Diagnosis

Coral reef.

Exploring the Use of Nature-Based Solutions for Healthy Corals and Communities

Pupil Dilation Correlates With Improved Working Memory

Feedback Loop Melting West Antarctic Ice Sheet Uncovered

Supercomputer Simulation Unveils New Insights Into Membrane Fusion

News

Launch of DIRECT - An Innovative Medicines Initiative Project for Personalized Medicine in Diabetes

Academia and the pharmaceutical industry working together in the fight against diabetes.

Theratechnologies Announces a Supply, Distribution and Licensing Agreement with Actelion

Agreement provides Actelion with the exclusive commercialization rights to tesamorelin in Canada.

Cholinesterases, a Target of Pharmacology and Toxicology

This review’s main focus is on cholinesterases as targets of toxins and drugs. The biochemistry of AChE and BuChE is also discussed. Drugs and toxins are divided in chapters according to target sites.

Transcriptional and Posttranscriptional Regulation of HIV-1 Gene Expression

The transcription factors that control YAP gene expression are unknown. This study demonstrates that ß-catenin/TCF4 complexes bind a DNA enhancer element within the first intron of the YAP gene to drive YAP expression in CRC cells.

Shire Announces European Approval of Manufacturing Facility for VPRIV®

EMA approval adds significant capacity for the manufacture of Shire’s enzyme replacement therapies.

Boehringer Ingelheim and Xencor Enter a Collaboration Agreement

Antibodies engineered with Xencor’s proprietary Xtend™ technology for increasing antibody half-life.

JHS Secures Multi-Million Dollar Contracts to Manufacture Sterile Parenteral Products

Company has secured contracts with four innovator life science companies.

OGT Signs Licensing Deal for Colorectal Cancer Biomarkers

OGT has entered into an exclusive licensing agreement with Inven2.

FDA Approves Gen-Probe's PROGENSA® PCA3 Assay

Company reveals first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.

Study on Pivot-Point Vibration of Molecular Bond-Rupture Events by Quartz Crystal Microbalance for Biomedical Diagnostics

Molecular bond-rupture scanning is an effective method for the measurement of the energy level necessary to break a bond and distinguishing specific and nonspecific binding of biological molecules.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter